Takeover & acquisition readiness
Clarify the regulatory pathway, decision points and information requirements before resources are committed to the wrong structure or timetable.
Takeover · Acquisition · Investment
See the regulatory risk before it becomes deal risk.
Independent healthcare advisory for founders, acquirers, investors and boards navigating a takeover, acquisition, capital event or exit.
Discuss a Transaction
Confidential, focused and commercially aware
Built for
Healthcare founders
Strategic buyers
Investment partners
Lenders & boards
Regulatory intelligence
A clean data room can still hide a fragile service.
Healthcare transactions carry risks that conventional financial and legal diligence may not fully expose. Registration scope, leadership capacity, clinical governance and evidence quality can all affect whether an asset is safe to acquire, fund or scale.
Aegis connects the regulatory position to the commercial decision. We identify what needs closer examination, translate findings into practical deal implications and define what must happen before and after completion.
What can erode value
The liabilities rarely sit in one document.
They sit between the registered activities, the operating model, the workforce, the evidence and what actually happens in practice. That is where regulatory exposure becomes operational cost.
Transaction risk signals
- Registration does not match current services or locations
- Governance depends heavily on one individual
- Policies exist but evidence of implementation is weak
- Historic incidents or complaints lack clear closure
- Growth plans exceed leadership or workforce capacity
- Post-deal changes create unplanned CQC dependencies
Advisory scope
Support across the full transaction lifecycle.
Engage Aegis for a focused review at one stage or connect the work into a wider acquisition, growth or exit programme.
Regulatory due diligence
Review registration, ratings, governance, incidents, workforce controls and assurance evidence to expose liabilities that may affect value or completion.
Investor & board assurance
Turn fragmented compliance information into a clear, defensible position that investors, lenders and boards can understand and interrogate.
Post-acquisition integration
Build the first 30, 60 and 90-day governance plan, assign accountability and stabilise regulatory controls while the organisation changes around them.
Growth & capital planning
Test new locations, services and operating models against CQC, workforce and governance requirements before growth assumptions become commitments.
Exit preparation
Strengthen governance, evidence and operational readiness ahead of diligence so avoidable compliance gaps do not weaken confidence or negotiating position.
How an engagement works
Stage 01
Stage 02
Stage 03
Stage 04
Clear decisions, not a longer list of documents.
Define the decision
We establish the transaction stage, stakeholders, timetable and questions the work must answer.
Interrogate the position
We review the evidence, test assumptions and identify material gaps requiring deeper examination.
Translate the risk
Findings are framed in practical terms: impact, priority, ownership and implications for the deal.
Control the next step
You receive a focused action plan for completion, integration, investment assurance or exit readiness.
Bring regulatory clarity into the room before the decision is made.
Share the situation in confidence and we’ll identify the most useful next step for the transaction.